Breaking News
Urgent Call to Wyndham Shareholders Act Quickly on Choice Hotels Exchange Offer
Choice Hotels International, Inc. is urging Wyndham Hotels & Resorts, Inc. shareholders to act quickly and tender their shares into...
Barclays Analyst Maintains EqualWeight Rating on Equinix Increases Price Target
Barclays analyst Brendan Lynch has decided to keep his Equal-Weight rating on Equinix (NASDAQ:EQIX) while increasing the price target to...
Analyzing Array Technologies A Neutral Perspective
Keybanc analyst Sophie Karp has recently started covering Array Technologies (NASDAQ: ARRY) with a Sector Weight rating, indicating a neutral...
Analysts Remain Bullish on American Tower with Price Target Adjustments
Barclays analyst Brendan Lynch remains bullish on American Tower (NYSE: AMT), reiterating an Overweight rating and bumping up the price...
Financial Analyst Maintains Reduce Rating on bluebird bio and Downgrades Home Depot
On March 5, 2024, Morten Herholdt, an analyst at HSBC, decided to maintain his Reduce rating on bluebird bio (NASDAQ:BLUE)...
Analyst Initiates Coverage on Installed Building Products with Buy Rating and 275 Price Target
On March 5, 2024, analyst Kurt Yinger from DA Davidson has started covering Installed Building Products (NYSE: IBP) with a...
Groundbreaking Findings from Omnipod 5 Trial Show Improved Glycemic Control in Type 1 and Type 2 Diabetes Patients
Insulet is gearing up to unveil the groundbreaking findings from the inaugural Omnipod 5 randomized controlled trial (OP5-003) at the...
Concerns Over Teslas Performance and Value
Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, expressed worries about Tesla's recent performance despite the success of...
Bark Inc Receives Buy Rating Upgrade from Jefferies Analyst
On March 5, 2024, Bark Inc. (NYSE: BARK) received a significant upgrade from analyst Kaumil Gajrawala at Jefferies. Moving from...
Analysts Bullish on Avidity Biosciences Raise Price Targets
On March 5, 2024, Chardan Capital analyst Keay Nakae reiterated a Buy rating on Avidity Biosciences (NASDAQ: RNA) and upped...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
